The Catechol-O-Methyltransferase Val158Met Polymorphism Contributes to the Risk of Breast Cancer in the Chinese Population: An Updated Meta-Analysis

Guo-Xing WAN; Yu-Wen CAO; Wen-Qin LI; Yu-Cong LI; Feng LI.
Journal of Breast Cancer ; : 149-156, 2014.
Artículo en Inglés | WPRIM | ID: wpr-110221

Documentos relacionados

  1. Catechol-O-methyltransferase Val158Met polymorphism and breast cancer risk in Asian population.
  2. Impact of Genetic Variants on Postoperative Pain and Fentanyl Dose Requirement in Patients Undergoing Major Breast Surgery: A Candidate Gene Association Study.
  3. Genetic polymorphisms and haplotype of hormone-related genes are associated with the risk of breast cancer in Chinese women.
  4. COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies.
  5. Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls.
  6. Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.
  7. [Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].
  8. Is catechol-O-methyltransferase gene associated with temporomandibular disorders? A systematic review and meta-analysis.
  9. Drinking green tea modestly reduces breast cancer risk.
  10. Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls.